What Gelfoam Treats: Main Uses and Benefits

This product is commonly used to help with symptoms related to physical discomfort during various operative procedures. It is relevant when control of bleeding by pressure, ligature, or other conventional procedures is judged to be ineffective or impractical.

Controlling Localized Bleeding

This product is applied to address localized hemorrhage, specifically symptoms of diffuse surface bleeding. It is commonly used across surgical specialties such as neurosurgery and orthopedic surgery, as well as in procedures involving bony tissues or deep, irregular cavities. The product supports symptomatic relief in contexts marked by increased discomfort.

“This application is relevant for managing active, troublesome bleeding and supports general well-being during symptomatic phases.”

This provides supportive relief that helps with clot stabilization, and is useful in scenarios where symptoms escalate temporarily, which helps maintain a sense of stability.

---

Quick Fact: Supportive Relief for Symptoms of Hemorrhage

This product is applied in addressing conditions characterized by periods of heightened symptoms, offering symptomatic relief that helps patients cope more steadily with difficult episodes.

Regulatory References

1. U.S. Food and Drug Administration (FDA)

This section outlines the official rules for the use of Gelfoam (Absorbable Gelatin) based on regulatory documents from agencies like the U.S. Food and Drug Administration (FDA).

Contraindications and Prohibited Use

• Porcine Allergy: Gelfoam must not be used in patients with a known allergy or hypersensitivity to porcine collagen or other pig-derived products, as the risk of a severe allergic reaction exists.
• Intravascular Compartments: Application in blood vessels or other intravascular compartments is strictly prohibited due to the serious risk of blood vessel blockage (embolization).
• Skin Closure: The product should not be used for the closure of skin incisions as its presence may mechanically interfere with the healing process of the wound edges.

---

Restricted and Conditional Eligibility

Restriction Category	Regulatory Status
Infection	Not recommended in the presence of frank infection; use with caution in contaminated areas.
Coagulation Disorders	Not recommended as the primary treatment for inherited or acquired blood clotting disorders.
Specific Sites	Must not be placed near the cerebral ventricular space or used for postpartum hemorrhage or menorrhagia.

Eligibility for pediatric patients, as well as the safety during pregnancy and lactation, has not been definitively established in controlled clinical studies, according to regulatory data.

Interactions with other medicines and products

Official regulatory documents define the interaction profile of Gelfoam primarily through restrictions related to procedural use and combinations with specific agents or medical devices.

Documented Interaction Restrictions

The following limitations are specified in official labeling and relate to potential interference or lack of established safety when used in conjunction with Gelfoam:

• Methyl-methacrylate Adhesives: Use of Gelfoam is not recommended in conjunction with methyl-methacrylate adhesives (used to attach prosthetic devices to bone surfaces). This restriction is a precaution, as similar agents, such as microfibrillar collagen, have been reported to reduce the strength of these adhesives.
• Autologous Blood Salvage Circuits: Gelfoam should not be used in conjunction with autologous blood salvage circuits because the safety and efficacy of this specific combined use have not been evaluated in controlled clinical trials.
• Antibiotic Solutions or Powders: It is not recommended that Gelfoam be saturated with an antibiotic solution or dusted with antibiotic powder.
• Other Agents (e.g., Topical Thrombin): The safety and efficacy of the combined use of Gelfoam with other hemostatic agents, such as topical thrombin, have not been evaluated in controlled clinical trials. If concurrent use is considered medically advisable, the specific product literature for the other agent must be consulted.

These constraints ensure the product is used within evaluated parameters and mitigate risks associated with unstudied combinations or product integrity.

How Gelfoam Works: Mechanistic Principles

Gelfoam functions purely through a physical and passive mechanism to achieve hemostasis. It is a porous, bioabsorbable gelatin matrix that, when placed at a site of hemorrhage, mechanically traps whole blood. This structure provides a large surface area for the adhesion and aggregation of platelets and the physical concentration of circulating hemostatic components. This interaction initiates the formation of a thrombus and facilitates the conversion of blood to a gelatinous mass.

The sponge's presence supports the local conversion of fibrinogen into fibrin, providing a stable lattice upon which the fibrin clot can polymerize and mature. This mechanical reinforcement supports the physical integrity and duration of localized hemostasis. Following its local function, the material undergoes gradual degradation in situ through enzymatic hydrolysis, primarily carried out by the body's proteolytic enzymes, resulting in complete bioabsorption within weeks.

How to Use Absorbable Gelatin (Gelfoam)

Absorbable Gelatin, marketed under the Gelfoam trade name, is strictly administered via topical application directly onto bleeding tissue surfaces during a surgical procedure. This approach aligns with its function as a local hemostatic agent and prevents systemic exposure.

Dosing and Preparation Principles

Official instructions mandate a functional dosing principle, requiring the use of the minimum amount necessary to achieve hemostasis. The material is not dosed by body weight or a fixed volume. Professionals may cut the sponge or film into the appropriate size or mix the powder with sterile saline to create a putty-like paste, such as adding 3–4 mL of saline to a 1-gram vial of powder.

The application is a single procedural use under sterile conditions. The material can be applied dry or wet; if wet, it must be pre-saturated in sterile isotonic sodium chloride solution or thrombin before use and then gently squeezed to remove excess fluid.

Procedural Constraints and Duration

Once applied to the bleeding site, the material must be held in place with moderate pressure. Procedural guidelines address the material's resorbable nature, defining its usage over time. When left in situ in soft tissues, it is generally absorbed by the body within four to six weeks. However, the material should be removed whenever possible once hemostasis is complete, especially from areas such as bony foramina or laminectomy sites, to prevent pressure effects as the material swells. There are no explicit adjustments for age- or organ-function specific dosing, as use is localized.

Gelfoam: Recent Clinical Evidence

Gelfoam is an absorbable gelatin sponge used in surgical settings as an adjunct to hemostasis, meaning it is applied to bleeding surfaces to help control capillary, venous, and arteriolar bleeding when conventional methods may be impractical. Its mode of action is considered primarily mechanical, providing a physical matrix that assists in the formation of a stable blood clot.

---

Key Areas of Study

Clinical studies have evaluated Gelfoam's performance across various surgical specialties, with recent research exploring its role in specific high-risk patient groups and novel applications.

• Cardiothoracic Surgery: Research has investigated the use of absorbable gelatin powder on cut bone surfaces, such as the sternum during cardiopulmonary bypass surgery. One controlled clinical study indicated that the use of the gelatin powder was associated with less blood loss compared to a no-treatment control group.
• Dental/Oral Surgery: The efficacy of Gelfoam in controlling post-extraction bleeding, particularly in patients taking anticoagulant therapy (e.g., aspirin or warfarin), has been a focus of recent comparative trials. These studies assess outcomes such as bleeding severity, time to hemostasis, and pain levels.
• New Applications: Studies are also exploring Gelfoam's use as a biodegradable delivery vehicle for local agents, such as anti-inflammatory and analgesic drugs, in procedures like spine surgeries, evaluating effects on postoperative pain and neurological function.

---

Safety and Biodegradation

When not used in excessive amounts, Gelfoam is designed to be completely absorbed by the body, typically within four to six weeks when placed in soft tissues, with minimal scar formation. Documented adverse events observed in clinical practice, though rare, include the potential for localized foreign body reactions or serving as a focus for infection or abscess formation, particularly in unapproved use settings.

Common questions about Gelfoam (FAQ)

---

Q: Is Gelfoam the same as surgical glue or stitches?

According to the official product classification, Gelfoam is a hemostatic device, meaning it is a sponge used to control oozing blood on tissue surfaces during a procedure. This function is different from surgical glues or stitches, which are designed for wound closure. The official warnings state that Gelfoam is contraindicated for the closure of skin incisions because its presence may mechanically interfere with the healing of the skin edges.

---

Q: Is Gelfoam used to help bones or tissues heal faster?

Official information indicates that Gelfoam's primary intended purpose is to provide a physical matrix to help stop bleeding (hemostasis) when conventional methods are impractical. It is not indicated or labeled as a product to accelerate the healing of bone or other tissues. The device's primary function is described as providing a physical matrix to support blood clot formation.

---

Q: Why is Gelfoam only meant for use by a healthcare professional?

Official documentation indicates that professional use is required due to the sterile administration needed during surgery. The restriction is in place because its use requires professional judgment to mitigate potential risks, such as nerve damage from swelling in confined bony spaces or vascular complications from improper placement.

---

Q: Are there any religious or dietary restrictions related to Gelfoam's ingredients?

Official labeling states that Gelfoam is prepared from purified porcine skin gelatin. While the regulatory documents include a contraindication for patients with a known allergy to this substance, they do not provide specific guidance on religious or dietary restrictions. Patients with concerns about the use of porcine-derived materials can review the product's composition with their treating professional.

---

Q: Have there been any major product recalls or safety alerts for Gelfoam?

Regulatory agencies continuously monitor medical devices for safety. Information regarding official actions, such as recalls or safety alerts, is publicly documented and available on the websites of these regulatory bodies. This process is in place to provide transparency regarding product safety.

---

Q: How quickly does Gelfoam work to control bleeding?

Official directions indicate that Gelfoam is placed on the bleeding site using moderate pressure until hemostasis (the stopping of blood flow) is achieved. The physical mechanism of the sponge begins working immediately to trap blood and concentrate clotting factors. The time required to achieve hemostasis may be influenced by the location and severity of the bleeding.

---

Q: Does Gelfoam contain latex?

Official product information for Gelfoam Sterile Sponge confirms that the product is designated as latex-free. Natural rubber latex has not been used in its manufacturing, and the product is also labeled as preservative-free and gluten-free.

---

Q: Does Gelfoam pose a risk of transmitting diseases?

Gelfoam Sterile Sponge is supplied as a sterile product manufactured from purified porcine gelatin. The regulatory labeling for the stand-alone sponge does not typically carry a warning about the transmission of infectious agents. However, some combination products that use gelatin sponges with thrombin derived from human plasma carry warnings about a theoretical risk of transmitting infectious agents, such as viruses.

---

Q: Is Gelfoam available under different brand names globally?

The product is widely known by the brand name Gelfoam, but it is also marketed under other trade names, such as Surgifoam. Additionally, in some markets, the absorbable gelatin component is part of a combination product that may use a different name to reflect the inclusion of other agents.

---

Q: What is the shelf life of Gelfoam before it is used?

Gelfoam is supplied with a specific expiration date printed on its packaging. Adherence to this shelf life is required by the manufacturer. Official storage guidelines also require the product to be kept at a controlled room temperature, and it must not be used if the package has been opened or damaged.

---

Q: What is the official classification of Gelfoam by health regulators (e.g., FDA)?

Gelfoam is regulated by the U.S. Food and Drug Administration (FDA) as a medical device, specifically an absorbable gelatin sponge. This classification indicates it is an adjunctive product intended for use as a hemostatic device during surgical procedures.

How to Store and Dispose of Gelfoam

Gelfoam is a sterile, single-use product whose storage and disposal requirements are designed to maintain its sterility and physical integrity.

Official Storage Requirements

Storage Temperature: Store at controlled room temperature, typically 25 C (77 F), allowing for excursions between 15 C and 30 C.

Handling and Packaging: The product is supplied sterile and must not be used if the package is torn or damaged. Contents are intended for single use only; use aseptic technique when opening. Do not resterilize the product.

Official Disposal Requirements

Unused or opened contents must be discarded immediately following the procedure according to institutional medical waste policies. Disposal should prevent environmental release, and care must be taken to avoid heat or flame due to potential fire hazards with fine particles.